1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.3 MARKET SCOPE 15
1.3.1 MARKETS COVERED 15
1.3.2 YEARS CONSIDERED FOR THE STUDY 16
1.4 CURRENCY 16
1.5 LIMITATIONS 16
1.6 STAKEHOLDERS 17

2 RESEARCH METHODOLOGY 18
2.1 RESEARCH DATA 18
2.1.1 SECONDARY DATA 20
2.1.1.1 Secondary sources 20
2.1.2 PRIMARY DATA 22
2.1.3 PRIMARY SOURCES 23
2.1.3.1 key insights from primary sources 24
2.1.3.2 Market size estimation methodology 24
2.1.4 MARKET DATA ESTIMATION AND TRIANGULATION 26
2.2 ASSUMPTIONS 27

3 EXECUTIVE SUMMARY 28

4 PREMIUM INSIGHTS 32
4.1 INFUSION PUMP SOFTWARE MARKET OVERVIEW 32
4.2 GEOGRAPHIC ANALYSIS: EUROPEAN INFUSION PUMP SOFTWARE MARKET SHARE,
BY TYPE, 2019 33
4.3 INFUSION PUMP SOFTWARE MARKET SHARE, BY INDICATION, 2019 VS. 2024 34
4.4 INFUSION PUMP SOFTWARE MARKET SHARE, BY TYPE, 2019 VS. 2024 34
4.5 INFUSION PUMP SOFTWARE MARKET SHARE, BY END USER, 2019 VS. 2024 35
4.6 INFUSION PUMP SOFTWARE MARKET: GEOGRAPHICAL SNAPSHOT 35

5 MARKET OVERVIEW 36
5.1 INTRODUCTION 36
5.2 MARKET DYNAMICS 36
5.2.1 MARKET DRIVERS 37
5.2.1.1 Increasing incidence of chronic diseases and rapid growth in geriatric population 37
5.2.1.2 Growing number of surgical procedures performed 38
5.2.1.3 Rising demand for ambulatory and home care infusion pumps 39
5.2.1.4 Technological developments 39
5.2.2 MARKET RESTRAINTS 40
5.2.2.1 Frequent product recalls of infusion pumps 40
5.2.3 MARKET OPPORTUNITIES 41
5.2.3.1 Untapped emerging markets 41
5.2.3.2 Growing adoption of specialty infusion systems 41
5.2.4 CHALLENGES 42
5.2.4.1 Increasing incidence of medication errors and lack of wireless connectivity in most hospitals 42

6 INFUSION PUMP SOFTWARE MARKET, BY TYPE 43
6.1 INTRODUCTION 44
6.2 DOSE ERROR REDUCTION SOFTWARE (DERS) 46
6.2.1 INCREASING INCIDENCE OF MEDICATION ERRORS IS DRIVING THE DEMAND FOR DERS IN INFUSION PUMPS 46
6.3 CLINICAL WORKFLOW SOFTWARE 47
6.3.1 CLINICAL WORKFLOW SOFTWARE ENABLES AUTOMATION OF THE ENTIRE PROCESS OF A PATIENT’S ASSESSMENT AND TREATMENT 47
6.4 INTEROPERABILITY SOFTWARE 48
6.4.1 INTEROPERABILITY SOFTWARE HELPS IN REDUCING MANUAL PROGRAMMING ERRORS 48
6.5 OTHERS 49

7 INFUSION PUMP SOFTWARE MARKET, BY INDICATION 50
7.1 INTRODUCTION 51
7.2 GENERAL INFUSION 52
7.2.1 AVAILABILITY OF SAFER AND EFFICIENT INFUSION PUMPS TO PROPEL THE MARKET FOR GENERAL INFUSION 52
7.3 PAIN & ANESTHESIA MANAGEMENT 53
7.3.1 HIGH INCIDENCE OF CHRONIC PAIN WILL DRIVE THE MARKET FOR PAIN MANAGEMENT 53
7.4 INSULIN INFUSION 54
7.4.1 SIGNIFICANT INCREASE IN THE GLOBAL PREVALENCE OF DIABETES WILL DRIVE MARKET GROWTH 54
7.5 CHEMOTHERAPY 55
7.5.1 DEMAND FOR CONTROLLED AND TARGETED DELIVERY OF MEDICATION TO DRIVE THE CHEMOTHERAPY MARKET 55
7.6 ENTERAL INFUSION 56
7.6.1 INFUSION PUMPS FACILITATE CONTINUOUS AND CONTROLLED PARENTERAL FLOW 56
7.7 OTHER INDICATIONS 57
?

8 INFUSION PUMP SOFTWARE MARKET, BY END USER 59
8.1 INTRODUCTION 60
8.2 HOSPITALS 61
8.2.1 HOSPITALS DOMINATE THE INFUSION PUMP SOFTWARE MARKET, BY END USER 61
8.3 AMBULATORY CARE SETTINGS 62
8.3.1 NEED TO REDUCE HEALTHCARE EXPENDITURE HAS BOOSTED THE PREFERENCE FOR AMBULATORY CARE 62
8.4 HOME CARE SETTINGS 63
8.4.1 RISING ACCEPTANCE AND COST-EFFICIENCY OF HOME CARE PRODUCTS HAVE DRIVEN THEIR USE 63
8.5 ACADEMIC & RESEARCH INSTITUTES 64
8.5.1 RISING DRUG DISCOVERY ACTIVITY AND INCIDENCE OF MEDICATION ERRORS IS DRIVING MARKET GROWTH 64

9 INFUSION PUMP SOFTWARE MARKET, BY REGION 66
9.1 INTRODUCTION 67
9.2 NORTH AMERICA 68
9.2.1 US 72
9.2.1.1 US is the largest market for infusion pump software 72
9.2.2 CANADA 74
9.2.2.1 Favorable reimbursement scenario for infusion pumps to propel the market in Canada 74
9.3 EUROPE 76
9.3.1 GERMANY 80
9.3.1.1 Germany is the fastest-growing market for infusion pump software in Europe 80
9.3.2 FRANCE 82
9.3.2.1 The healthcare system in France is among the best in the world 82
9.3.3 UK 84
9.3.3.1 High number of medication errors in the UK to drive market growth 84
9.3.4 ROE 86
9.4 APAC 88
9.4.1 CHINA 92
9.4.1.1 Growing investments in healthcare infrastructure to support market growth 92
9.4.2 JAPAN 94
9.4.2.1 Rapid growth in the geriatric population and the rising prevalence of age-related illnesses to drive market growth 94
9.4.3 INDIA 96
9.4.3.1 High prevalence of lifestyle diseases to drive the market for infusion pump software 96
9.4.4 ROAPAC 98
9.5 REST OF THE WORLD 100

10 COMPETITIVE LANDSCAPE 104
10.1 OVERVIEW 104
10.1.1 MARKET RANKING OF PLAYERS, 2018 105
10.2 COMPETITIVE LEADERSHIP MAPPING 106
10.2.1 VISIONARY LEADERS 106
10.2.2 INNOVATORS 106
10.2.3 DYNAMIC DIFFERENTIATORS 106
10.2.4 EMERGING COMPANIES 107
10.3 COMPETITIVE SCENARIO 108
10.3.1 PRODUCT LAUNCHES 108
10.3.2 EXPANSIONS 109
10.3.3 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 110
10.3.4 ACQUISITIONS 111

11 COMPANY PROFILES 112
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1 BECTON, DICKINSON AND COMPANY (BD) 112
11.2 B. BRAUN MELSUNGEN AG (B. BRAUN) 115
11.3 BAXTER INTERNATIONAL INC. (BAXTER) 118
11.4 FRESENIUS KABI 121
11.5 ICU MEDICAL, INC. (ICU MEDICAL) 123
11.6 MEDTRONIC PLC (MEDTRONIC) 125
11.7 MOOG INC. (MOOG) 128
11.8 SMITHS MEDICAL (A DIVISION OF SMITHS GROUP PLC) 130
11.9 TERUMO CORPORATION 132
11.10 ROCHE DIAGNOSTICS (A DIVISION OF F. HOFFMANN- LA ROCHE LTD.) 134
11.11 YPSOMED AG (YPSOMED) 136
11.12 MICREL MEDICAL DEVICES 139
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

12 APPENDIX 140
12.1 DISCUSSION GUIDE 140
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 143
12.3 AVAILABLE CUSTOMIZATIONS 145
12.4 RELATED REPORTS 145
12.5 AUTHOR DETAILS 146